醋酸左炔諾孕酮

醋酸左炔諾孕酮
臨床資料
其他名稱	LNG-A; LNGA; 3-Ketonorgestimate; Levonorgestrel 17β-acetate; D-(–)-Norgestrel 17β-acetate; 17α-Ethynyl-18-methylestr-4-en-17β-ol-3-one 17β-acetate; 17β-Acetoxy-13β-ethyl-17α-ethynylgon-4-en-3-one
藥物類別（英語：Drug class）	孕激素
識別資訊
	IUPAC命名法 [(8R,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate; ;
CAS號	13732-69-9（; 18290-31-8）
PubChem CID	62954;
ChemSpider	56666;
UNII	VF642934XZ;
CompTox Dashboard（英語：CompTox Chemicals Dashboard） (EPA)	DTXSID301314299 ;
ECHA InfoCard	100.123.252
化學資訊
化學式	C23H30O3
摩爾質量	354.49 g·mol−1
3D模型（JSmol（英語：JSmol））	交互式圖像;
	SMILES CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)OC(=O)C)CCC4=CC(=O)CC[C@H]34;
	InChI InChI=1S/C23H30O3/c1-4-22-12-10-19-18-9-7-17(25)14-16(18)6-8-20(19)21(22)11-13-23(22,5-2)26-15(3)24/h2,14,18-21H,4,6-13H2,1,3H3/t18-,19+,20+,21-,22-,23-/m0/s1; Key:YDQDJLTYVZAOQX-GOMYTPFNSA-N;

醋酸左炔諾孕酮（英語：Levonorgestrel acetate，縮寫LNG-A，化學名：左炔諾孕酮-17β-乙酸酯，levonorgestrel 17β-acetate），是一種有機化合物，分子式為C₂₃H₃₀O₃，屬於19-去甲孕酮型孕激素，從未上市銷售^[1]^[2]^[3]^[4]。

參考文獻

^ Naderi S, Fotherby K. Long-acting contraceptive agents: in vitro hydrolysis of esters of norethisterone and levonorgestrel. Steroids. 1983, 41 (3): 397–417. PMID 6419410. S2CID 28094296. doi:10.1016/0039-128x(83)90110-1.
^ Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration (PDF). Climacteric. 2005, 8 (Suppl 1): 3–63 [2024-10-01]. PMID 16112947. S2CID 24616324. doi:10.1080/13697130500148875. （原始內容存檔 (PDF)於2016-08-22）.
^ Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, Thijssen JH. Classification and pharmacology of progestins. Maturitas. 2008, 61 (1–2): 171–80. PMID 19434889. doi:10.1016/j.maturitas.2008.11.013.
^ Alvarez-Sanchez F, Brache V, Jackanicz T, Faundes A. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles. Contraception. 1992, 46 (4): 387–98. PMID 1486777. doi:10.1016/0010-7824(92)90101-x.

[pmid6419410-2] Naderi S, Fotherby K. Long-acting contraceptive agents: in vitro hydrolysis of esters of norethisterone and levonorgestrel. Steroids. 1983, 41 (3): 397–417. PMID 6419410. S2CID 28094296. doi:10.1016/0039-128x(83)90110-1.

[pmid16112947-3] Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration (PDF). Climacteric. 2005, 8 (Suppl 1): 3–63 [2024-10-01]. PMID 16112947. S2CID 24616324. doi:10.1080/13697130500148875. （原始內容存檔 (PDF)於2016-08-22）.

[pmid19434889-4] Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, Thijssen JH. Classification and pharmacology of progestins. Maturitas. 2008, 61 (1–2): 171–80. PMID 19434889. doi:10.1016/j.maturitas.2008.11.013.

[pmid1486777-5] Alvarez-Sanchez F, Brache V, Jackanicz T, Faundes A. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles. Contraception. 1992, 46 (4): 387–98. PMID 1486777. doi:10.1016/0010-7824(92)90101-x.

[1]

[2]

[3]

[4]